GB/T 16886.4-2022
Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood (English Version)

Standard No.
GB/T 16886.4-2022
Language
Chinese, Available in English version
Release Date
2022
Published By
国家市场监督管理总局、中国国家标准化管理委员会
Latest
GB/T 16886.4-2022
Replace
GB/T 16886.4-2003
Scope
This document specifies the general requirements for the evaluation of the interaction between medical devices and blood. This document gives: a) Classification of medical devices that come into contact with blood according to the intended use and contact time specified in ISO 10993 1; b) Basic evaluation principles for the interaction between devices and blood; c) According to the classification of specific devices, combined with the basic principles of testing and The scientific basis is the principle of selecting and combining the corresponding experiments. Due to the limited understanding of the interaction between the device and blood and the precision of the test, detailed test requirements cannot be specified. Therefore, this document only provides a general description of biological evaluation, and may not provide sufficient test method guidance for specific devices. . Changes to this document do not invalidate tests conducted in accordance with previous editions. For marketed devices with a history of safe clinical use, it is not recommended to conduct additional tests according to this revision.

GB/T 16886.4-2022 Referenced Document

  • ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process

GB/T 16886.4-2022 history

  • 2022 GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood
  • 2003 GB/T 16886.4-2003 Biological evaluation of medical devices--Part 4: Selection of tests for interactions with blood
Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood

GB/T 16886.4-2022 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved